Part I. Fundamental Studies on the Determination of thyrotropin (TSH) using McKenzie's method.
Male and female SM strain mice (15-17Gm) were used as assay animals. It was found convenient to use a 4 point assay technique with 6 observations for each of 2 doses of the standard thyrotropin and the unknown preparation. Thus with a total of 24 mice.
The range of linear responsiveness was 0.05 to 0.4mU (Y=90.9X +81.5) and the index of precision (λ) was 0.35. (5=31.5, b=90.9) The smallest amount of thyrotropin detected by this technique was 0.025mU. The recovery was 95 per ceut from the serum of normal subject.
Part II. Bio-assay of thyrotropin (TSH) in human blood
1) The average concentration of TSH in the serum of 17 normal subjects was 0.107 (0.053-0.177) mU per ml and in 2 normal subjects, serum TSH could not be detected by this method.
2) The average concentration of TSH in the serum of 14 primary hypothyroidism was 0.365 (0.207-0.989) mU per ml. On the contrary, in 2 secondary hypothyroidism, serum TSH could not be detected by this method.
3) The average concentration of TSH in the serum of 18 hyperthyroidism was 0.228 (0.066-1.062) mU per ml and in 3 hyperthyroidism, serum TSH could not be detected. The TSH concentration in the sera of hyperthyroidism was greater than in normal subjects but smaller than in primary hypothyroidism. The TSH concentration of hyperthyroidism with exophthalmos was slighty greater than without exophthalmos, but no abnormal high level.
4) The TSH concentration in the sera of simple goitre was within the range of normal subjects and in Hashimoto's disease, postoperative thyroid cancer and subacute thyroiditis was slightly higher than in normal subjects. In acromegaly and Simmonds' diseasease, serum TSH could not be detected. In Cushing's syndrome and Addison's disease a definite tendency of serum TSH could not be found.
Part III. The clinical studies on the abnormal thyroid stimulator (abnormal TSH) of hyperthyroidism.
The abnormal TSH of hyperthyroidism was distinguished from the standard thyrotropin by its prolonged action in an assay for thyrotropin. Using mice previously injected with I
131, a maximal increase in circulating radioactivity occured 2-3 hrs. after the intravenous injection of standard thyrotropin, normal human serum or whole serum from patients with myxedema. The injection of serum from patients with hyperthyroidism, hoverer, produced maximal increase in the circulating I
131 only after 9-12 hrs.
1) The abnormal TSH was sought in the serum of 94 persons and was found in (a) 21 of 30 persons with uutreated hyperthyroidism, 20 of 29 persons with hyperthyroidism after I
131 therapy and 5 of 14 persons with hyperthyroidism after antithyroid medications ; (b) 2 of 9 normal subjects ; (c) 1 of 2 persons with subacute thyroiditis.
2) The level of the abnormal TSH showed a falling tendency after treatments. (I
131 therapy and antithyroid medications)
3) No specific correlation was found between clinical symptoms and the level of the abnormal TSH of hyperthyroidism.
4) No correlation was found between the presence of exophthalmos of hyperthyroidism and the level of the abnormal TSH.
View full abstract